Orion Pharma Limited (DSE:ORIONPHARM)
Bangladesh · Delayed Price · Currency is BDT 26.60
+0.40 (1.53%)
At close: May 5, 2026
Orion Pharma Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -595.3 | -415.28 | 318.12 | 640.94 | 846.08 | 939.06 |
Depreciation & Amortization | 576.04 | 634.4 | 588.7 | 601.12 | 498.45 | 1,019 |
Loss (Gain) From Sale of Investments | 0 | 0 | 2.86 | -0.21 | -0.08 | 5.93 |
Other Operating Activities | 412.3 | 425.53 | 432.84 | 256.66 | -225.31 | 528.16 |
Change in Accounts Receivable | -86.15 | -388.27 | 1,319 | 1,004 | -2,841 | -1,448 |
Change in Inventory | 561.77 | 192.79 | -96.04 | 45.45 | -263.32 | -133.11 |
Change in Accounts Payable | 66.83 | 667.23 | -1,134 | -327.19 | 3,226 | 1,603 |
Change in Other Net Operating Assets | -113.69 | -12.27 | 155.36 | 272.12 | -79.3 | 77.52 |
Operating Cash Flow | 821.8 | 1,104 | 1,587 | 2,493 | 1,162 | 2,592 |
Operating Cash Flow Growth | -60.79% | -30.41% | -36.36% | 114.60% | -55.17% | 37.68% |
Capital Expenditures | -421 | -767.16 | -1,948 | -3,859 | -2,667 | -4,277 |
Sale of Property, Plant & Equipment | 152.21 | 152.21 | 371.11 | - | - | - |
Cash Acquisitions | -61.81 | -62.94 | 386.09 | -1,376 | -379.31 | -1,633 |
Investment in Securities | -8.36 | -8.36 | -0.22 | 0.01 | -8.6 | 0.03 |
Other Investing Activities | 2.82 | 13.45 | 24.06 | 27.28 | 19.68 | 45.44 |
Investing Cash Flow | -336.14 | -672.8 | -1,167 | -5,208 | -3,035 | -5,864 |
Short-Term Debt Issued | - | - | 16.21 | 11.2 | 387.98 | 392.27 |
Long-Term Debt Issued | - | - | 764.9 | 3,311 | 1,784 | 3,131 |
Total Debt Issued | 240.03 | - | 781.11 | 3,322 | 2,172 | 3,523 |
Short-Term Debt Repaid | - | -62.48 | - | - | - | - |
Long-Term Debt Repaid | - | -281.23 | -22.33 | -28.36 | -33.66 | -40.63 |
Total Debt Repaid | -581.03 | -343.71 | -22.33 | -28.36 | -33.66 | -40.63 |
Net Debt Issued (Repaid) | -341 | -343.71 | 758.78 | 3,293 | 2,138 | 3,482 |
Common Dividends Paid | -0.46 | -8.21 | -269.9 | -152.94 | -324.54 | -340.17 |
Dividends Paid | -0.46 | -8.21 | -269.9 | -152.94 | -324.54 | -340.17 |
Other Financing Activities | -135.89 | -155.04 | -890.42 | -401.76 | -249.56 | -488.68 |
Financing Cash Flow | -477.35 | -506.96 | -401.55 | 2,739 | 1,564 | 2,654 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | 0 | -0 | 0 | -0 |
Net Cash Flow | 8.31 | -75.63 | 17.62 | 23.97 | -308.86 | -619.18 |
Free Cash Flow | 400.8 | 336.97 | -361.87 | -1,366 | -1,505 | -1,685 |
Free Cash Flow Margin | 13.31% | 8.25% | -3.41% | -9.81% | -15.58% | -15.56% |
Free Cash Flow Per Share | 1.71 | 1.44 | -1.55 | -5.84 | -6.43 | -7.20 |
Cash Interest Paid | 155.04 | 155.04 | 890.42 | 401.76 | 249.56 | 488.68 |
Cash Income Tax Paid | 45.65 | 45.65 | 194.54 | 117.03 | 95.73 | 40.91 |
Levered Free Cash Flow | -532.62 | 269.21 | -618.16 | -3,066 | -1,366 | -36.58 |
Unlevered Free Cash Flow | -274.66 | 539.14 | -372.3 | -2,974 | -1,257 | 103.06 |
Change in Working Capital | 428.76 | 459.48 | 244.04 | 994.67 | 42.63 | 99.74 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.